First National Bank Of Omaha
Source: SEC Form 13F · as of Mar 2026First National Bank Of Omaha holds 19 biotech & pharma companies tracked by BioSniper, totaling $159.0M in value as of Mar 2026 (SEC Form 13F).
Companies held
19
Total value held
$159.0M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 115,030 | $28.0M |
| ABTABBOTT LABORATORIES | 172,814 | $17.7M |
| AMGNAMGEN INC | 48,054 | $16.8M |
| LLYELI LILLY & Co | 15,455 | $14.1M |
| MRKMerck & Co., Inc. | 115,017 | $13.7M |
| PMPhilip Morris International Inc | 81,638 | $13.5M |
| ZBHZimmer Biomet Holdings Inc. | 146,265 | $13.1M |
| DGXQuest Diagnostics Incorporated | 60,694 | $11.9M |
| ABBVAbbVie Inc. | 38,518 | $8.3M |
| NVSNovartis AG | 32,671 | $4.9M |
| ELANElanco Animal Health Inc | 158,459 | $3.7M |
| UTHRUNITED THERAPEUTICS Corp | 5,738 | $3.4M |
| ICLRICON plc | 28,370 | $3.1M |
| PFEPFIZER INC | 97,734 | $2.7M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 6,857 | $1.8M |
| CAHCardinal Health Inc. | 5,322 | $1.1M |
| PBHPrestige Consumer Healthcare Inc. | 8,419 | $499K |
| ZTSZoetis Inc. | 3,331 | $387K |
| BMYBRISTOL MYERS SQUIBB CO | 4,165 | $249K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.